Novo Nordisk A/S ADR buy Kepler Capital Markets
Start price
13.03.25
/
50%
€71.00
Target price
13.03.26
-
Performance (%)
-52.68%
End price
14.03.26
€33.60
Summary
This prediction ended on 14.03.26 with a price of €33.60. The BUY prediction by Kepler_Capital_Marke for Novo Nordisk A/S ADR performed very badly with a performance of -52.68%. Dividends of €1.10 are taken into consideration when calculating the performance. Kepler_Capital_Marke has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 4.518% | 4.518% | -35.839% |
| iShares Core DAX® | -0.372% | 8.404% | 6.759% |
| iShares Nasdaq 100 | 2.269% | 15.232% | 36.176% |
| iShares Nikkei 225® | 1.433% | 14.424% | 43.114% |
| iShares S&P 500 | 1.216% | 10.492% | 27.276% |
Comments by Kepler_Capital_Marke for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Kepler Capital Markets from a "hold" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von Kepler_Capital_Marke gewählte maximale Laufzeit wurde überschritten